We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.74%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$4.88B
AUM Growth
-$338M
Cap. Flow
-$638M
Cap. Flow %
-13.08%
Top 10 Hldgs %
41.5%
Holding
103
New
20
Increased
15
Reduced
27
Closed
26

Top Buys

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$248M
2
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
+$141M
3
DELL
DELL INC
DELL
+$136M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$129M
5
MSFT icon
Microsoft
MSFT
+$125M

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$302M
2
YHOO
Yahoo Inc
YHOO
+$267M
3
SFD
SMITHFIELD FOODS,INC
SFD
+$165M
4
AZO icon
AutoZone
AZO
+$144M
5
BKNG icon
Booking.com
BKNG
+$132M

Sector Composition

Rank Sector Weight
1 Communication Services 13.19%
2 Healthcare 10.25%
3 Real Estate 10.23%
4 Consumer Discretionary 10.03%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDU icon
51
New Oriental
EDU
$8.96B
$12.4M 0.26%
+500,000
New +$11.4M
GWPH
52
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.1M 0.21%
584,000
+24,000
+4% +$276K
AMGN icon
53
Amgen
AMGN
$210B
$9.85M 0.2%
+88,000
New +$9.54M
PCO
54
DELISTED
Pendrell Corporation - Class A
PCO
$7.75M 0.16%
3,997
– –
RUE
55
DELISTED
RUE21 INC COM STK (DE)
RUE
$7.46M 0.15%
+185,000
New +$7.66M
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.45M 0.15%
2,223,071
– –
CIM
57
Chimera Investment
CIM
$1.06B
$7.01M 0.14%
153,667
– –
PACT
58
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
$6.83M 0.14%
+1,160,000
New +$7.72M
HCBK
59
DELISTED
HUDSON CITY BANCORP INC
HCBK
$6.8M 0.14%
+751,907
New +$7.09M
NKTR icon
60
Nektar Therapeutics
NKTR
$2.46B
$6.38M 0.13%
+40,667
New +$7.52M
OREX
61
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.83M 0.12%
95,000
– –
LNCO
62
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$5.73M 0.12%
+196,500
New +$5.7M
TTM
63
DELISTED
Tata Motors Limited
TTM
$5.26M 0.11%
197,514
– –
ANAC
64
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$4.78M 0.1%
450,000
-187,500
-29% -$1.64M
PBY
65
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$4.75M 0.1%
380,495
-355,315
-48% -$4.3M
JCP
66
DELISTED
J.C. Penney Company, Inc.
JCP
$4.41M 0.09%
+500,000
New +$7.13M
VIRX
67
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.55M 0.07%
3,405
+1,143
+51% +$1.22M
ARQL
68
DELISTED
Arqule Inc
ARQL
$3.41M 0.07%
1,464,699
– –
HK
69
DELISTED
Halcon Resources Corporation
HK
$3.28M 0.07%
4,292
-10,062
-70% -$9.17M
MACK
70
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.06M 0.06%
102,356
-33,328
-25% -$1.17M
STML
71
DELISTED
Stemline Therapeutics, Inc.
STML
$2.67M 0.05%
59,000
-76,000
-56% -$2.48M
ZTS icon
72
Zoetis
ZTS
$31.9B
$1.69M 0.03%
54,179
-98,100
-64% -$3.01M
FBIO icon
73
Fortress Biotech
FBIO
$90.4M
$824K 0.02%
7,828
– –
ASIA
74
DELISTED
ASIAINFO-LINKAGE INC COM STK (DE)
ASIA
$319K 0.01%
+27,662
New +$320K
OPK icon
75
Opko Health
OPK
$978M
$284K 0.01%
+32,246
New +$259K
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Farallon Capital Management held 103 positions worth $4.88B, down 6.5% from $5.22B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Farallon Capital Management withdrew a net $638M in Q3 2013, closing 26 positions and reducing 27 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $302M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Farallon Capital Management opened a new position in Twenty-First Century Fox, Inc. Class A worth $138M.

  • Farallon Capital Management's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,105,000 shares worth $138M.
  • Farallon Capital Management added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $248M increase.
  • Farallon Capital Management's biggest Q3 2013 reduction was Yahoo Inc, cutting an estimated $267M.
  • Farallon Capital Management fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $302M.
  • Farallon Capital Management's ten largest holdings make up 42% of its $4.88B portfolio in Q3 2013.
  • Farallon Capital Management opened 20 new positions and closed 26 in Q3 2013.
  • Farallon Capital Management's portfolio value fell 6.5% quarter-over-quarter to $4.88B.

Based on Farallon Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.